Sulfoxonium, [(5S)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-2,6-dioxo-6-(phenylmethoxy)hexyl]dimethyl-, inner salt

Catalog No. :
ACCAWQ802
CAS No. :
1133931-71-1
Molecular Formula :
C20H29NO6S
Molecular Weight :
411.52

IUPAC Name:-

Sulfoxonium, [(5S)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-2,6-dioxo-6-(phenylmethoxy)hexyl]dimethyl-, inner salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$335.00Login to see priceInquiryInquiry
5g97%$2466.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSulfoxonium, [(5S)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-2,6-dioxo-6-(phenylmethoxy)hexyl]dimethyl-, inner salt
Molecular FormulaC20H29NO6S
Molecular Weight411.52
SMILESCC(C)(C)OC(=O)[N-][C@@H](CCC(=O)C[S+](C)(C)=O)C(=O)OCC1=CC=CC=C1
InChI KeyJQGGTMAVDMYLIC-KRWDZBQOSA-N
SynonymSulfoxonium, [(5S)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-2,6-dioxo-6-(phenylmethoxy)hexyl]dimethyl-, inner salt;(5S)-5-[[(1,1-Dimethylethoxy)carbonyl]amino]-2,6-dioxo-6-(phenylmethoxy)hexyl]dimethyl-sulfoxonium Inner Salt
CAS No.1133931-71-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCAWQ802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCAWQ802 route product structure diagram
    ACCAWQ8021133931-71-1
Inquiry

2. ACCAWQ802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCAWQ802 route product structure diagram
    ACCAWQ8021133931-71-1
Inquiry

Comments (0)